All Stories

  1. Comparison of the sequential use of mifepristone and dinoprostone vaginal insert with dinoprostone vaginal insert as the only method for induction of labor in very unripe cervix: a secondary analysis of a multicenter real‐word evidence study
  2. Comparative analysis of the accuracy of ultrasonography and magnetic resonance imaging in estimating fetal weight
  3. Adaptation of the fetus to sequential cardiotocographic examinations and the development of closed loops of self-regulation
  4. Use of dinoprostone vaginal insert for cervical ripening and labor induction in routine obstetrical clinical practice: a multicenter study based on real-world evidence
  5. Modern concepts of preeclampsia development and prediction
  6. Obstetric and neonatal outcomes of spontaneous labor with a large fetus depending on the gestational age
  7. Evaluation of the utero-placental blood flow by the method of tissue oxymetry at the neuroaxial analgesia of childbirth
  8. Reasons for the Increase and Ways to Reduce the Frequency of Cesarean Sections in Modern Obstetrics
  9. Experience of dinoprostone vaginal insert using for cervical ripening and induction of labor
  10. Clinical and immunological characteristics of women in labor with COVID-19 and their newborn babies
  11. Determination of the prerequisites for fetal macrosomia using biomarkers in the first trimester of pregnancy
  12. PREDICTORS OF SUCCESSFUL LABOR PREINDUCTION WITH MIFEPRISTONE
  13. PLASMA LEVELS OF CELL ADHESION MOLECULES IN NORMAL PREGNANCY AND PREECLAMPSIA
  14. A randomised controlled trial of outpatient mifepristone usage for cervical ripening.
  15. The frequency of caesarean section and neonatal outcomes depending on management strategy for large‑for‑gestational‑age pregnancy
  16. Comparative evaluation of test systems for determining premature rupture of membranes
  17. Obstetric and neonatal outcomes of different management strategies in fetal macrosomia
  18. CURRENT STATE OF ANESTHESIA FOR LABOR
  19. Cell subpopulation composition and cytokine content in peripheral blood before spontaneous and induced labor
  20. Comparison of the course and outcomes of pregnancies complicated by hypertensive disorders
  21. Birth trauma in newborns
  22. Regulation of the Placental Renin-Angiotensin-Aldosterone System in Early- and Late-Onset Preeclampsia
  23. The use of a vaginal therapeutic system with prostaglandin for induction of labor
  24. Risk factors for birth injury
  25. Antenatal and intrapartum risk factors associated with fetal hypoxia in labor
  26. 462 Maternal and perinatal outcomes of pregnancies complicated by preeclampsia
  27. 463 Synthetic osmotic dilators dilapan-s vs double balloon catheter ripening of the cervix for induction of labour in nulliparous
  28. Initiation of labor activity as a multifactor mechanism of communication between maternal and fetal compartments
  29. Mechanical methods for induction of labor
  30. Diagnostic Potential of Exosomal HypoxamiRs in the Context of Hypoxia–Sumoylation–HypoxamiRs in Early Onset Preeclampsia at the Preclinical Stage
  31. Comparison of outpatient with inpatient mifepristone usage for cervical ripening: study protocol for a randomized controlled trial
  32. Current views on the pathogenesis of fetal growth restriction
  33. The role of cell adhesion molecules in the pathogenesis of preeclampsia
  34. Relationship between the umbilical cord blood acid-base status and neonatal hypoxic-ischemic encephalopathy
  35. Fetal adaptation to cardiotocography as a criterion of fetal condition
  36. The state of and prospects for the introduction of artificial intelligence technologies in obstetric and gynecological practice
  37. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction
  38. Induction of labour before 41 weeks or expectant management until 42 weeks: data from observational studies, randomized trials, systematic reviews and meta-analysis
  39. Ultrasound criteria for estimating the duration of spontaneous vaginal deliveries
  40. Verifying fetal scalp lactate testing results as measured by a portable lactate analyzer
  41. Umbilical cord arterial lactate levels in newborns with and without acidosis
  42. Modern principles of cardiotocography in childbirth
  43. Correlation of cardiotocographic parameters witt the risk of neonatal hypoxic ischemic encephalopathy
  44. Comparison of the efficiency of labor induction in full term and late term pregnancies
  45. Modification of combined spinal-epidural analgesia in labor
  46. SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity
  47. Clinical and morphological features of the placenta in acute intrauterine hypoxia during childbirth
  48. Indicators of umbilical arterial blood acid-base status during spontaneous labor and cesarean section
  49. Comparison of cord blood lactate measurement by gas analyzer and portable electrochemical devices
  50. Content of Free Fetal DNA in Maternal Blood and Expression of DNA Recognition Receptors ZBP-1 in Placental Tissue in Preeclampsia and Preterm Labor
  51. Combination of mifepristone and Dilapan-S is more efficient for labor induction than Dilapan-S alone
  52. Clinical and economic effectiveness of a placental alpha-microglobulin-1 test and that of the clinical diagnosis of premature rupture of membranes
  53. Structural features of fetal membranes in preterm labor
  54. Diagnostic opportunities of echo elastography in obstetrics and gynecology
  55. Ultrasound during labor: techniques and practical application
  56. Umbilical cord blood acid-base balance and gas composition in relation to the use of epidural analgesia in vaginal delivery
  57. Experience of using a double balloon catheter for cervical ripening in the induction of labor
  58. Ultrasound assessment of fetal head position during labor and delivery
  59. Combined use of Dilapan-S and mifepristone for labour induction in nulliparous women
  60. Maternal plasma cell-free DNA in prediction of preeclampsia
  61. Peripheral blood cytokine levels in women according to the phase of the first period of labor
  62. The indicators of acid-base balance and the gas composition of umbilical cord arterial and venous blood in health and fetal hypoxia
  63. The dynamics of renin, angiotensin (1-7) and angiotensin II in severe and moderate preeclampsia
  64. Prevention, the algorithm of reference, anesthesia and intensive care for postpartum hemorrhage. Guidelines
  65. Prediction of and a risk group for delayed labor
  66. Extracellular DNA in the Dynamics of Uncomplicated Pregnancy
  67. Correction to: Abstracts
  68. Ways to standardise of fetometry in Russia: INTERGROWTH-21st project and its implementation
  69. Biochemical tests for the diagnosis of premature rupture of membranes
  70. Synthetic osmotic dilators in the induction of labour—An international multicentre observational study
  71. PMD53 - REMOVABLE DINOPROSTONE VAGINAL DELIVERY SYSTEM: COST-CONSEQUENCES MODEL FOR CENTRAL AND EASTERN EUROPE COUNTRIES
  72. Disturbancies in the balance of vasoconstrictors and vasodilatators in maternal blood plasma in the preeclampsia genesis
  73. Morphological and immunohistochemical features of foetal membranes in the pathogenesis of preterm labor
  74. NOD-1 expression in placental villi in pregnancy-related complications
  75. Abstracts
  76. Dynamics of Renin, Angiotensin II, and Angiotensin (1–7) during Pregnancy and Predisposition to Hypertension-Associated Complications
  77. Umbilical vein aneurysm: A clinical case and a review of literature
  78. Determination of umbilical cord blood acid-base status. Indications and techniques
  79. A comparison of tocolysis with nifedipine and atosiban in preterm labor
  80. The role of extracellular fetal DNA in predicting the great obstetric syndromes
  81. Features of the myometrial status during cesarean section with regard to amniorrhea and birth activity: A clinical and morphological study
  82. A change in the concentration of extracellular DNA during pregnancy
  83. Corrigendum to “Identification of potential early biomarkers of preeclampsia” [Placenta (2018) 61–71]
  84. Modern tocolysis and adverse effects of tocolytics
  85. Identification of potential early biomarkers of preeclampsia
  86. Giant hemangioma of the placenta
  87. DAI-1 Receptor Expression in Placenta in Earlyand Late-Onset Preeclampsia
  88. Efficacy of atosiban for threatened preterm birth
  89. Outcomes of mifepristone usage for cervical ripening and induction of labour in full-term pregnancy. Randomized controlled trial
  90. Expression analysis of tollip, the inhibitor of inflammatory signaling cascade, in placenta samples in cases of early onset preeclampsia
  91. Perinatal prevention of diseases caused by Group B streptococcus (clinical protocol)
  92. Maternal and perinatal outcomes in early and late preeclampsia
  93. Umbilical cord blood cytokines during spontaneous labor and caesarean section
  94. Synthetic Osmotic Dilator Prior to Induction of Labor: Outcomes From International Observational E-Registry [13C]
  95. Morphological Features of Mesenhymal Stroma Cells of Chorionic Villi
  96. Diagnosis and treatment of intrahepatic cholestasis of pregnancy. Clinical recommendations
  97. 4 Oral Presentations
  98. 5 Poster Presentations
  99. COMPAREMENT OF LOCALIZA ATOSIBAN AND HEXOPRENALINE IN PREMATURE DELIVERY BEFORE 32 AND AFTER 32 WEEKS OF PREGNANCY
  100. Течение родов в современных условиях
  101. Fetal oxytocin levels at term with and without labour
  102. Current views of the etiology of prolonged pregnancy
  103. Misoprostol Vaginal Insert in Labor Induction: A Cost–Consequences Model for 5 European Countries—An Economic Evaluation Supported with Literature Review and Retrospective Data Collection
  104. The course and outcomes of labor in relation to management tactics during prolonged pregnancy
  105. The clinical and economic efficiency of direct electrocardiography with ST-segment analysis in the evaluation of fetal status
  106. Influence of magnesium therapy on ion homeostasis in women with preeclampsia
  107. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor
  108. Caspase Expression in Placental Terminal Villi in Spontaneous and Induced Pregnancy
  109. Misoprostol Vaginal Insert Pharmacoeconomic Model for 5 European Countries
  110. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery
  111. Distribution of trophoblast proliferative markers in women with missed abortion following assisted reproductive technologies
  112. O658 MOLECULAR GENETIC RISK FACTORS OF OBSTETRICAL COMPLICATIONS AND ASSISTED REPRODUCTIVE TECHNOLOGIES
  113. Expression of proliferative receptors on trophoblastic cells in women after assisted reproductive technologies
  114. Expression of Carbohydrate Metabolism Markers in Full-Term Spontaneous and Induced Pregnancy
  115. Markers of Transmembrane and Energy Exchange in Cells of Terminal Placental Villi in Spontaneous and Induced Pregnancy
  116. Peroxisome Proliferator-Activated Receptors of Trophoblast Cells in Miscarriage
  117. First trimester serum and ultrasound marker distribution in singleton pregnancy conceived with assisted reproductive technology
  118. Mifepristone versus intracervical prostaglandin E2 gel for cervical ripening and labor induction
  119. Thrombophilic genetic polymorphisms and placental histomorphology in pregnancies conceived by assisted reproductive technology
  120. 1 THROMBOPHILIA POLYMORPHISMS IN WOMEN WITH PREGNANCY CONCEIVED BY ASSISTED REPRODUCTIVE TECHNOLOGY
  121. Features of antibacterial therapy intraamniotic infections
  122. Treatment of the uteroplacental insufficiency, caused by intraamniotic infection